Agree with your statements and thoughts Eshmun...May I suggest all remaining shareholders start to demand some action by calling head office one after the other.....Have you tried calling Eshmun..?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%